Nuestro Servicio de Digestivo recibe el Premio Ciudad de Pontevedra 🙌

Un premio como este, de los ciudadanos a los que nos debemos, es un honor que supera con creces cualquier otro. Y un refuerzo extra para seguir avanzando e innovando todos juntos 💪

Key recommendations in portal vein thrombosis in patients with cirrhosis:

✅Identify recent thrombosis and extent
✅Anticoagulate if recent & >50% obstruction
❌ No anticoagulants if chronic cavernomas
✅DOACs safe if compensated
🤏 TIPS sometimes
💡 Image every 3m

doi.org/10.1053/j.ga...

#LiverSky

⚠️ A recent study in patients with cirrhosis and portal hypertension shows that preoperative placement of TIPS is associated with increased postoperative mortality 🤨

doi.org/10.1097/hc9....

#LiverSky #MedSky

Albumin is the closest thing to a "universal remedy" in cirrhosis

We use it to treat different complications, with good evidence but also with debatable or negative evidence

Excellent analysis by Jonel Trebicka & @ggarciatsao.bsky.social

doi.org/10.1097/hep.0000000000000521

#LiverSky

Decompensated cirrhosis has often been considered the irreversible, terminal stage of liver disease, but this is not actually always the case

Have you heard of the concept of cirrhosis "recompensation"?

➡️ doi.org/10.1016/j.jhepr.2024.101233

#LiverSky

Today marks the end of my journey as Associate Editor at Liver International. It’s been a fantastic experience, and I’m confident the journal will continue to grow 📈

I encourage researchers to submit their valuable work and contribute to its success!

#liverSky

⁉️ Crees que la implantación de la #IA generativa en tu trabajo es lenta o inexistente? @emollick.bsky.social lo explica en Co-Intelligence:
🚫 Exceso de centralización y burocracia
🐢 Estrategias obsoletas
🔑 El verdadero poder está en quienes conocen los problemas reales y ya están probando soluciones

Mañana cuento en el congreso de Endocrinología SEEDO2024 nuestro proyecto de asistente de #IA generativa con Atención Primaria, y en la diapositiva inicial hay una incorporación sutil que utilizo por primera vez ...

1/2
📢 Excited to share a study by BCLC group, where I had the opportunity to collaborate, exploring the use of generative #AI in LI-RADS categorization of liver MRI reports:

🌟 Specificity 0.96 for LR-5 & moderate agreement with consensus κ=0.54

doi.org/10.1186/s13244-024-01850-1

#LiverSky #MedSky

Hoy he visto un ordenador cuántico ... o no

Un día inolvidable! 🎉 Ganamos dos premios nacionales:


🏆 Best in Class: Mejor Servicio de Patología Digestiva en España
🏆 Ennova Health: Mejor proyecto en #IA por COMTA, nuestro asistente de IA generativa para Atención Primaria

Nada de esto sería posible sin un equipo increíble 💙

##MedSky #AI

The authors provide an example in the Supplement 2, as well as the process of collecting and analyzing the responses

🔗 bit.ly/4eBpMnt

1/2
Does #AI improve medical diagnosis? 🩺🤖

A recent study in JAMA Network Open examined the impact of GPT-4 in medical diagnostics:

1️⃣ Physicians + GPT-4: no significant improvement compared to traditional resources 🤔

2️⃣ GPT-4 alone: 92% accuracy, outperforming physicians (74%) 🤯

🔓 t.co/2LCVy1zHGA

🆕 Study hints at potential benefits of G-CSF in treating severe alcoholic hepatitis

👍 90-day survival beats no treatment, matches steroids
⚠️ Limited data, cause of death & long-term effects unknown
⚖️ Sepsis & encephalopathy rates similar between groups

🔓 doi.org/10.1111/liv....

#LiverSky #MedSky

Healthy Galician food 😊

Remembering my friends abroad @juanabraldes.bsky.social @augustonyc.bsky.social & Rubén Hernaez (who is not on BlueSky … yet)

Positive Phase III RCT results for semaglutide vs placebo in the treatment of fatty liver (#MASH) + advanced fibrosis (no cirrhosis)

✅ Significant reduction in inflammation & modest in fibrosis

Press release from Novo Nordisk ➡️ bit.ly/4et4Hvo

Full data presentation next week at #TLM24

#LiverSky

Intriguing findings from 🇪🇺 RWD comparing efficacy of Atezo/Beva vs Lenva in treating HCC:

📊 Overall survival was similar
⚠️ AZ/BV was linked to a ⬆️ risk of hepatic decompensation
⁉️ Do we focus on the study’s limitations, or adjust first-line drug choices? Both?

🔓 doi.org/10.1097/hc9....

#liverSky